Youmanitarian 11 Jun 2021

Bir sonraki

Otomatik oynatma

Kerrville, Texas flooding update: Several confirmed dead as evacuations, rescue efforts continue alo

Youmanitarian · 24 Görünümler

KEYNOTE-100 update: pembrolizumab in patients with advanced recurrent ovarian cancer

7 Görünümler

TAKE ACTION

Donations would go to support charities for Nasıl Yapılır ve Stil

İçinde Nasıl Yapılır ve Stil

Ursula Matulonis, MD, Dana-Farber Cancer Institute, Boston, MA, discusses the results of the KEYNOTE-100 trial (NCT02674061) of pembrolizumab in advanced recurrent ovarian cancer patients. Importantly, no significant difference in response rate was found between heavily and less heavily pretreated patients. This interview was recorded via an online conference call with The Video Journal of Oncology (VJOncology).

Daha fazla göster

More ways to take action

Explore ways that you can help bring a solution to this issue.

Create Youms with
hashtags Nasıl Yapılır ve Stil

Create a challenge to
bring awareness to this issue for people to complete

Create a fundraiser to
support a charity that tackle this issue

Volunteer at charitable organization
that support this cause

Create a movement page dedicated to this cause to bring awareness.

Start a uCharity for this cause and invite people to join it to support this cause

Bir sonraki

Otomatik oynatma

Kerrville, Texas flooding update: Several confirmed dead as evacuations, rescue efforts continue alo

Youmanitarian · 24 Görünümler

Lütfen 18 yaşın altındaysanız bu siteye erişemeyeceğinizi unutmayın.

Bir sonraki

KEYNOTE-100 update: pembrolizumab in patients with advanced recurrent ovarian cancer

Bir sonraki

Kategoriler

Bir ödeme yöntemi seçin